TY - JOUR
T1 - Medical costs in patients with heart failure after acute heart failure events
T2 - one-year follow-up study
AU - Kim, Eugene
AU - Kwon, Hye Young
AU - Baek, Sang Hong
AU - Lee, Haeyoung
AU - Yoo, Byung Su
AU - Kang, Seok Min
AU - Ahn, Youngkeun
AU - Yang, Bong Min
N1 - Publisher Copyright:
© 2017 Informa UK Limited, trading as Taylor & Francis Group.
PY - 2018/3/4
Y1 - 2018/3/4
N2 - Aims: This study investigated annual medical costs using real-world data focusing on acute heart failure. Methods: The data were retrospectively collected from six tertiary hospitals in South Korea. Overall, 330 patients who were hospitalized for acute heart failure between January 2011 and July 2012 were selected. Data were collected on their follow-up medical visits for 1 year, including medical costs incurred toward treatment. Those who died within the observational period or who had no records of follow-up visits were excluded. Annual per patient medical costs were estimated according to the type of medical services, and factors contributing to the costs using Gamma Generalized Linear Models (GLM) with log link were analyzed. Results: On average, total annual medical costs for each patient were USD 6,199 (±9,675), with hospitalization accounting for 95% of the total expenses. Hospitalization cost USD 5,904 (±9,666) per patient. Those who are re-admitted have 88.5% higher medical expenditure than those who have not been re-admitted in 1 year, and patients using intensive care units have 19.6% higher expenditure than those who do not. When the number of hospital days increased by 1 day, medical expenses increased by 6.7%. Limitations: Outpatient drug costs were not included. There is a possibility that medical expenses for AHF may have been under-estimated. Conclusion: It was found that hospitalization resulted in substantial costs for treatment of heart failure in South Korea, especially in patients with an acute heart failure event. Prevention strategies and appropriate management programs that would reduce both frequency of hospitalization and length of stay for patients with the underlying risk of heart failure are needed.
AB - Aims: This study investigated annual medical costs using real-world data focusing on acute heart failure. Methods: The data were retrospectively collected from six tertiary hospitals in South Korea. Overall, 330 patients who were hospitalized for acute heart failure between January 2011 and July 2012 were selected. Data were collected on their follow-up medical visits for 1 year, including medical costs incurred toward treatment. Those who died within the observational period or who had no records of follow-up visits were excluded. Annual per patient medical costs were estimated according to the type of medical services, and factors contributing to the costs using Gamma Generalized Linear Models (GLM) with log link were analyzed. Results: On average, total annual medical costs for each patient were USD 6,199 (±9,675), with hospitalization accounting for 95% of the total expenses. Hospitalization cost USD 5,904 (±9,666) per patient. Those who are re-admitted have 88.5% higher medical expenditure than those who have not been re-admitted in 1 year, and patients using intensive care units have 19.6% higher expenditure than those who do not. When the number of hospital days increased by 1 day, medical expenses increased by 6.7%. Limitations: Outpatient drug costs were not included. There is a possibility that medical expenses for AHF may have been under-estimated. Conclusion: It was found that hospitalization resulted in substantial costs for treatment of heart failure in South Korea, especially in patients with an acute heart failure event. Prevention strategies and appropriate management programs that would reduce both frequency of hospitalization and length of stay for patients with the underlying risk of heart failure are needed.
UR - http://www.scopus.com/inward/record.url?scp=85035129880&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85035129880&partnerID=8YFLogxK
U2 - 10.1080/13696998.2017.1403922
DO - 10.1080/13696998.2017.1403922
M3 - Article
C2 - 29125033
AN - SCOPUS:85035129880
SN - 1369-6998
VL - 21
SP - 288
EP - 293
JO - Journal of Medical Economics
JF - Journal of Medical Economics
IS - 3
ER -